欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2968/001
药品名称Vesomni
活性成分
    • Solifenacin succinate 6.0 mg
    • Tamsulosin hydrochloride 400.0 µg
剂型Modified-release tablet
上市许可持有人Astellas Pharma Europe BV Sylviusweg 62 2333 BE Leiden The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Vesomni
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Hungary (HU)
      VESOMNI 6 mg/0,4 mg módosított hatóanyag-leadású tabletta
    • Bulgaria (BG)
      Vesomni
    • Romania (RO)
      VESOMNI 6 mg/0,4 mg comprimate cu eliberare modificată
    • Slovenia (SI)
    • Croatia (HR)
    • Denmark (DK)
      Vesomni
    • Belgium (BE)
      Vesomni
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Vesomni 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung
    • Spain (ES)
    • Greece (GR)
      VESOMNI
    • Sweden (SE)
    • Norway (NO)
      Urizia
    • Finland (FI)
    • Czechia (CZ)
      Vestona
    • Slovakia (SK)
      Vesomni 6 mg/0,4 mg tablety s riadeným uvoľňovaním
许可日期2013/10/07
最近更新日期2025/02/03
药物ATC编码
    • G04CA Alpha-adrenoreceptor antagonists
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase